Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
about
New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperonesLiver-targeted gene therapy: Approaches and challengesModulators of microglia: a patent review.Gene editing technology as an approach to the treatment of liver diseases.Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.
P2860
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@ast
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@en
type
label
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@ast
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@en
prefLabel
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@ast
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@en
P2860
P1476
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.
@en
P2093
Elena L Aronovich
Perry B Hackett
P2860
P356
10.1016/J.YMGME.2014.09.011
P577
2014-10-07T00:00:00Z